Buy and Sell Signals, and Other Market Perspectives Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Buy and Sell Signals, and Other Market Perspectives

SPY 689.17

+0.2%

Dec 11 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

To: codfish23 who wrote (144934)	5/6/2020 11:30:07 AM
From: oldirtybastard	5 Recommendations Read Replies (1) of 220081

for sure, the list of drugs that affects QT interval is very long, and degree of effect matters as well. I've not delved deep into it but assume the effect HCQ has on QT is immaterial for >90% of the all-age population who have no cardiac conduction abnormalities at baseline. It is on the physician and patient to weigh that risk on an individual basis as part of the treatment decision, as in the case of every other QT-relevant drug. Saying this drug would cause deaths for this 10% is very disingenous as most of them would not get the drug. And BTW, 200,000 physician eror deaths per year overall i think, so we have some leeway with getting this specific one right, or rather a high tolerance for mistakes lol

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next